Drug
Lanadelumab-flyo
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hereditary Angioedema | 1,197 | 853.6 | 1,372.1 | signal |
| 2 | Pharyngeal Swelling | 121 | 84.8 | 88.1 | signal |
| 3 | Weight Fluctuation | 84 | 53.8 | 55.3 | signal |
| 4 | Insurance Issue | 113 | 50.8 | 52.6 | signal |
| 5 | Product Availability Issue | 79 | 23.4 | 24.0 | signal |
| 6 | Body Height Decreased | 32 | 19.7 | 19.9 | signal |
| 7 | Poor Venous Access | 30 | 19.3 | 19.5 | signal |
| 8 | Stress | 138 | 12.7 | 13.3 | signal |
| 9 | Seasonal Allergy | 25 | 11.8 | 11.8 | signal |
| 10 | Pregnancy | 35 | 11.5 | 11.6 | signal |
| 11 | Infusion Site Pain | 22 | 11.4 | 11.5 | signal |
| 12 | Treatment Noncompliance | 92 | 11.2 | 11.5 | signal |
| 13 | Intentional Product Use Issue | 146 | 11.0 | 11.5 | signal |
| 14 | Product Prescribing Error | 39 | 10.9 | 11.1 | signal |
| 15 | Complication Associated With Device | 19 | 9.5 | 9.6 | signal |
| 16 | Drug Effect Less Than Expected | 19 | 8.9 | 9.0 | signal |
| 17 | Limb Injury | 33 | 8.1 | 8.2 | signal |
| 18 | Ligament Sprain | 12 | 8.1 | 8.1 | signal |
| 19 | Therapy Change | 11 | 7.6 | 7.6 | signal |
| 20 | Inability To Afford Medication | 11 | 7.4 | 7.4 | signal |
| 21 | Prescribed Overdose | 21 | 7.2 | 7.2 | signal |
| 22 | Weight Increased | 239 | 7.1 | 7.6 | signal |
| 23 | Product Prescribing Issue | 21 | 6.8 | 6.9 | signal |
| 24 | Injection Site Urticaria | 25 | 6.8 | 6.9 | signal |
| 25 | Inappropriate Schedule Of Product Administration | 178 | 6.7 | 7.0 | signal |
| 26 | Product Dose Omission Issue | 273 | 6.4 | 6.9 | signal |
| 27 | Skin Laceration | 10 | 6.1 | 6.2 | signal |
| 28 | Expired Product Administered | 30 | 6.0 | 6.0 | signal |
| 29 | Weight Decreased | 234 | 5.6 | 5.9 | signal |
| 30 | Product Use Issue | 156 | 5.5 | 5.8 | signal |
| 31 | Abdominal Distension | 86 | 5.5 | 5.6 | signal |
| 32 | Kidney Infection | 16 | 5.4 | 5.4 | signal |
| 33 | Illness | 81 | 5.3 | 5.5 | signal |
| 34 | Ovarian Cyst | 8 | 5.3 | 5.3 | signal |
| 35 | Temperature Intolerance | 8 | 5.2 | 5.2 | signal |
| 36 | Product Dose Omission In Error | 21 | 5.2 | 5.2 | signal |
| 37 | Nephrolithiasis | 35 | 5.1 | 5.1 | signal |
| 38 | Dysmenorrhoea | 10 | 5.1 | 5.1 | signal |
| 39 | Influenza | 84 | 5.0 | 5.1 | signal |
| 40 | Device Related Infection | 11 | 4.7 | 4.7 | signal |
| 41 | Injection Site Irritation | 9 | 4.7 | 4.7 | signal |
| 42 | Road Traffic Accident | 29 | 4.6 | 4.6 | signal |
| 43 | Swelling Face | 44 | 4.5 | 4.5 | signal |
| 44 | Swelling | 63 | 4.5 | 4.5 | signal |
| 45 | Gastroenteritis Viral | 12 | 4.4 | 4.4 | signal |
| 46 | Gastrointestinal Disorder | 57 | 4.3 | 4.3 | signal |
| 47 | Swollen Tongue | 20 | 4.2 | 4.3 | signal |
| 48 | Viral Infection | 21 | 4.2 | 4.2 | signal |
| 49 | Needle Issue | 18 | 4.2 | 4.2 | signal |
| 50 | Injection Site Reaction | 43 | 4.2 | 4.2 | signal |
| 51 | No Adverse Event | 110 | 4.1 | 4.2 | signal |
| 52 | Gastroenteritis | 9 | 4.1 | 4.1 | signal |
| 53 | Injection Site Swelling | 46 | 4.0 | 4.1 | signal |
| 54 | Condition Aggravated | 182 | 4.0 | 4.2 | signal |
| 55 | Incorrect Route Of Product Administration | 10 | 3.9 | 4.0 | signal |
| 56 | Covid-19 | 104 | 3.9 | 4.0 | signal |
| 57 | Injection Site Bruising | 46 | 3.9 | 3.9 | signal |
| 58 | Product Use Complaint | 9 | 3.8 | 3.9 | signal |
| 59 | Joint Dislocation | 6 | 3.8 | 3.8 | signal |
| 60 | Ear Infection | 15 | 3.7 | 3.8 | signal |
| 61 | Pharyngitis | 7 | 3.7 | 3.7 | signal |
| 62 | Brain Oedema | 7 | 3.7 | 3.7 | signal |
| 63 | Toothache | 10 | 3.7 | 3.7 | signal |
| 64 | Procedural Pain | 15 | 3.6 | 3.6 | signal |
| 65 | Tooth Infection | 7 | 3.5 | 3.5 | signal |
| 66 | Dermatitis Contact | 6 | 3.5 | 3.5 | signal |
| 67 | Spinal Disorder | 5 | 3.5 | 3.5 | signal |
| 68 | Migraine | 49 | 3.4 | 3.5 | signal |
| 69 | Musculoskeletal Chest Pain | 8 | 3.4 | 3.4 | signal |
| 70 | Syringe Issue | 9 | 3.4 | 3.4 | signal |
| 71 | Injection Site Erythema | 63 | 3.4 | 3.4 | signal |
| 72 | Accident | 6 | 3.3 | 3.3 | signal |
| 73 | Bladder Disorder | 5 | 3.3 | 3.3 | signal |
| 74 | Localised Infection | 12 | 3.3 | 3.3 | signal |
| 75 | Tooth Disorder | 11 | 3.3 | 3.3 | signal |
| 76 | Tooth Abscess | 5 | 3.2 | 3.2 | signal |
| 77 | Poor Quality Product Administered | 5 | 3.2 | 3.2 | signal |
| 78 | Injection Site Pain | 148 | 3.2 | 3.3 | signal |
| 79 | Sinusitis | 50 | 3.2 | 3.3 | signal |
| 80 | Scratch | 5 | 3.2 | 3.2 | signal |
| 81 | Post Procedural Complication | 9 | 3.1 | 3.1 | signal |
| 82 | Joint Injury | 10 | 3.1 | 3.1 | signal |
| 83 | Product Use In Unapproved Indication | 114 | 3.1 | 3.2 | signal |
| 84 | Pharyngitis Streptococcal | 5 | 3.1 | 3.1 | signal |
| 85 | Angioedema | 20 | 3.0 | 3.0 | signal |
| 86 | Sars-cov-2 Test Positive | 6 | 3.0 | 3.0 | signal |
| 87 | Nerve Compression | 4 | 2.9 | 2.9 | no signal |
| 88 | Aphonia | 6 | 2.9 | 2.9 | signal |
| 89 | Intestinal Obstruction | 16 | 2.8 | 2.8 | signal |
| 90 | Spinal Pain | 5 | 2.8 | 2.8 | signal |
| 91 | Lip Swelling | 14 | 2.8 | 2.8 | signal |
| 92 | Wrist Fracture | 5 | 2.8 | 2.8 | signal |
| 93 | Crying | 15 | 2.7 | 2.7 | signal |
| 94 | Urticaria | 68 | 2.7 | 2.7 | signal |
| 95 | Fear | 11 | 2.7 | 2.7 | signal |
| 96 | Eye Swelling | 15 | 2.7 | 2.7 | signal |
| 97 | Product Storage Error | 35 | 2.7 | 2.7 | signal |
| 98 | Anaphylactic Reaction | 22 | 2.7 | 2.7 | signal |
| 99 | Salivary Hypersecretion | 4 | 2.7 | 2.7 | no signal |
| 100 | Depressed Mood | 21 | 2.6 | 2.7 | signal |
| 101 | Therapy Interrupted | 27 | 2.6 | 2.6 | signal |
| 102 | Injection Site Discomfort | 4 | 2.6 | 2.6 | no signal |
| 103 | Exposure During Pregnancy | 24 | 2.6 | 2.6 | signal |
| 104 | Burning Sensation | 27 | 2.6 | 2.6 | signal |
| 105 | Pharyngeal Oedema | 6 | 2.5 | 2.6 | signal |
| 106 | Underdose | 28 | 2.5 | 2.6 | signal |
| 107 | Ill-defined Disorder | 23 | 2.5 | 2.5 | signal |
| 108 | Abdominal Pain Lower | 9 | 2.4 | 2.4 | signal |
| 109 | Post Procedural Haemorrhage | 4 | 2.3 | 2.3 | no signal |
| 110 | Systemic Lupus Erythematosus | 12 | 2.2 | 2.3 | signal |
| 111 | Injection Site Pruritus | 22 | 2.2 | 2.2 | signal |
| 112 | Injection Site Rash | 10 | 2.2 | 2.2 | signal |
| 113 | Lymphoma | 5 | 2.1 | 2.1 | no signal |
| 114 | Hernia | 6 | 2.1 | 2.1 | no signal |
| 115 | Injection Site Induration | 4 | 2.0 | 2.0 | no signal |
| 116 | Adverse Event | 28 | 2.0 | 2.0 | signal |
| 117 | Circumstance Or Information Capable Of Leading To Medication Error | 10 | 2.0 | 2.0 | no signal |
| 118 | Influenza Like Illness | 24 | 1.9 | 1.9 | no signal |
| 119 | Breast Pain | 3 | 1.9 | 1.9 | no signal |
| 120 | Application Site Pain | 6 | 1.8 | 1.8 | no signal |
| 121 | Maternal Exposure During Pregnancy | 24 | 1.8 | 1.8 | no signal |
| 122 | Incorrect Product Administration Duration | 5 | 1.6 | 1.6 | no signal |
| 123 | Hepatic Cytolysis | 3 | 1.6 | 1.6 | no signal |
| 124 | Injection Site Mass | 9 | 1.6 | 1.6 | no signal |
| 125 | Injection Site Discolouration | 3 | 1.6 | 1.6 | no signal |
| 126 | Product Preparation Error | 5 | 1.6 | 1.6 | no signal |
| 127 | Injection Site Extravasation | 3 | 1.6 | 1.6 | no signal |
| 128 | Menstruation Irregular | 6 | 1.5 | 1.5 | no signal |
| 129 | Therapeutic Response Shortened | 7 | 1.5 | 1.5 | no signal |
| 130 | Injection Site Haemorrhage | 15 | 1.3 | 1.3 | no signal |
| 131 | Abortion Spontaneous | 7 | 1.2 | 1.2 | no signal |
| 132 | Device Issue | 15 | 1.1 | 1.1 | no signal |
| 133 | Injury Associated With Device | 3 | 1.0 | 1.0 | no signal |
| 134 | Injection Site Warmth | 3 | 1.0 | 1.0 | no signal |
| 135 | Breast Cancer | 11 | 0.8 | 0.8 | no signal |
| 136 | Application Site Erythema | 3 | 0.8 | 0.8 | no signal |